Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia-Reference-Cited by-同舟云学术

Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia

Published:2021-02-25 Issue:8 Volume:384 Page:717-726
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Brannan Stephen K.¹,Sawchak Sharon¹,Miller Andrew C.¹,Lieberman Jeffrey A.¹,Paul Steven M.¹,Breier Alan¹

Affiliation:

1. From Karuna Therapeutics, Boston (S.K.B., S.S., A.C.M., S.M.P.); Columbia University Vagelos College of Physicians and Surgeons, New York (J.A.L.); and Indiana University School of Medicine, Indianapolis (A.B.).

Funder

Wellcome Trust

Karuna Therapeutics

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2017015

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials;Schizophrenia Research;2024-12

2. Dysfunction of the NMDA Receptor in the Pathophysiology of Schizophrenia and/or the Pathomechanisms of Treatment-Resistant Schizophrenia;Biomolecules;2024-09-06

3. Muscarinic receptor agonists in animal models of psychosis: protocol for a systematic review and meta-analysis;F1000Research;2024-09-06

4. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics;The World Journal of Biological Psychiatry;2024-09

5. Imaging the Vesicular Acetylcholine Transporter in Schizophrenia: A Positron Emission Tomography Study Using [18F]-VAT;Biological Psychiatry;2024-09